This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Indivior reaches $600 million resolution with FTC, DOJ, state attorneys general over Suboxone

By Max Fillion ( July 24, 2020, 19:51 GMT | Insight) -- Indivior will pay $600 million to settle civil and criminal allegations that it engaged in a scheme to illegally boost sales of its opioid treatment Suboxone. The company said today it has reached agreements with the US Federal Trade Commission, US Department of Justice and US state attorneys general.Indivior will pay $600 million to settle civil and criminal allegations that it engaged in a scheme to illegally boost sales of its opioid treatment Suboxone. The company said today it has reached agreements with the US Federal Trade Commission, US Department of Justice and US state attorneys general. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections